Orogen Therapeutics Announces Expansion of Board with Biopharma Leaders Mikael Dolsten and Dieter Weinand as Independent Non-Executive Directors.
WOBURN, Mass.–(BUSINESS WIRE)–Orogen Therapeutics, Inc., a private drug discovery company utilizing its proprietary, AI-enabled DNA encoded library (DEL)... Read more.
Realbotix to Showcase Humanoid Robots at Bitcoin 2025 Conference
LAS VEGAS–(BUSINESS WIRE)–Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”),... Read more.
Pagaya Reports First Quarter 2025 Results, GAAP Profitable Earlier than Expected
Reported strong performance across key metrics: Net income attributable to Pagaya shareholders of $8 million; up $29 million YoY Record Adjusted EBITDA of $80 million;... Read more.
TSOLife Secures $43 Million Series B Investment to Transform Senior Living Communities Through Person-Centered Data and AI Tools
TAMPA, Fla.–(BUSINESS WIRE)–#AI—TSOLife, the leading resident insight and experience platform for senior living operators, has completed a $43... Read more.
Ironwood Pharmaceuticals Reports First Quarter 2025 Results
– On track to achieve FY 2025 financial guidance; raised adjusted EBITDA guidance to greater than $105 million for 2025 – – LINZESS® (linaclotide)... Read more.
VectorY Therapeutics to Present Preclinical Data on Novel ALS Therapeutic Strategy at Target ALS Conference in Boston
~ New data show AAV-delivered antibody fragments targeting oxidized phosphatidylcholines (PC-OxPL), a species of oxidized phospholipids, thereby neutralizing TDP-43... Read more.
CDW Declares Quarterly Cash Dividend of $0.625 Per Share
Reinforces Ongoing Commitment to Delivering Value to Stockholders VERNON HILLS, Ill.–(BUSINESS WIRE)–CDW Corporation (Nasdaq: CDW), a leading multi-brand... Read more.
Palmer Square Capital BDC Inc. Announces First Quarter 2025 Financial Results
Declares Second Quarter 2025 Base Dividend of $0.36 Per Share with Supplemental Dividend Expected to be Announced in June MISSION WOODS, Kansas–(BUSINESS... Read more.
Delek Logistics Reports Record First Quarter 2025 Results
Net income of $39.0 million Reported Adjusted EBITDA of $116.5 million up 15% year over year On track to deliver $480 million to $520 million in full year Adjusted... Read more.
Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows
Study published in American Journal of Transplantation highlights strong sensitivity and specificity, along with a >37% reduction in false positives when using... Read more.